Ascendis Pharma A/S ADR (NASDAQ:ASND) shares, rose in value, with the stock price up by 4.36% to the previous day’s close as strong demand from buyers drove the stock to $165.05.
Actively observing the price movement in the last trading, the stock closed the session at $158.15, falling within a range of $155.65 and $165.41. The value of beta (5-year monthly) was 0.536. Referring to stock’s 52-week performance, its high was $169.37, and the low was $111.09. On the whole, ASND has fluctuated by -0.60% over the past month.
With the market capitalization of Ascendis Pharma A/S ADR currently standing at about $9.88 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-11.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 579.22M, with a low estimate of 83M and a high estimate of 107M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 93.99M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that ASND’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 100% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of ASND currently trading nearly 7.86% and 10.04% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 62.95, while the 7-day volatility ratio is showing 5.39% which for the 30-day chart, stands at 6.26%. Furthermore, Ascendis Pharma A/S ADR (ASND)’s beta value is 0.40, and its average true range (ATR) is 9.19.
A comparison of Ascendis Pharma A/S ADR (ASND) with its peers suggests the former has fared considerably weaker in the market. ASND showed an intraday change of 4.36% in last session, and over the past year, it grew by 16.64%%.
Data on historical trading for Ascendis Pharma A/S ADR (NASDAQ:ASND) indicates that the trading volumes over the past 10 days have averaged 0.6 and over the past 3 months, they’ve averaged 503.66K. According to company’s latest data on outstanding shares, there are 59.84 million shares outstanding.
Nearly 0.78% of Ascendis Pharma A/S ADR’s shares belong to company insiders and institutional investors own 106.72% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 4.31 million shares as on 2025-03-31, resulting in a short ratio of 9.75. According to the data, the short interest in Ascendis Pharma A/S ADR (ASND) stood at 862.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 3.98 million. The stock has risen by 19.89% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the ASND stock heading into the next quarter.
